Market Trends AstraZeneca to buy EsoBiotec in $1 billion deal to advance cell therapy ambition (AZN:NASDAQ)By admin8996erT0allMarch 17, 2025 Roland MagnussonEsoBiotec SA has entered into a definitive agreement to be acquired by AstraZeneca (NASDAQ:AZN) for up to $1 billion,…
